Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jan 2026 for Regeneron Pharmaceuticals, INC.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Joseph l. Goldstein: trading record in brief
Joseph l. Goldstein, listed as board member, appears in our data through filings on Regeneron Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 7 June 2021 and 2 January 2026, the trades on record add up to 10 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 6 January 2026, reports a share grant in Regeneron Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joseph l. Goldstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
155 shares0Common StockSEC:0001225474-26-000002:0
166 shares0Common StockSEC:0001968202-25-000004:0
2,707 shares@ US$625.6023.0% of flowCommon StockSEC:0001968202-24-000042:0
135 shares0Common StockSEC:0001968202-24-000023:0
3,613 shares@ US$482.6823.9% of flowCommon StockSEC:0001883850-23-000046:0
165 shares0Common StockSEC:0001883850-23-000018:0
2,431 shares@ US$374.1215.2% of flowCommon StockSEC:0001883850-22-000032:0
191 shares0Common StockSEC:0001708138-22-000006:0
2,479 shares@ US$380.9514.8% of flowCommon StockSEC:0001708138-21-000076:0
1,930 shares@ US$374.1211.0% of flowCommon StockSEC:0001237899-21-000008:0
10 of 10 declarations
